Abbott Labs Recalls Powdered Infant Formula in U.S.
September 23, 2019
Nutritional products and medical devices firm Abbott Laboratories issued a voluntary recall on September 17 for a lot of Calcilo CD powdered infant formula cans in the U.S., according to an company announcement on the website of the U.S. Food and Drug Administration (FDA).
Abbott said the recall was “due to an inconsistency in aroma and color in a small number of cans from this specific batch.” Those in possession of 13.2 oz Calcilo XD powder cans with the lot number 79696K80 are urged to not use the infant formula and contact the FDA for instructions on returning or replacing the product.
The U.S. recall was published by the FDA a day after the Canadian Food Inspection Agency (CFIA) announced that a similar voluntary recall for the lot of Calcilo infant formula was initiated by the company across eight provinces. CFIA said the impacted products were taken off shelves because of “rancidity and off-color.” Some illnesses have been reported among those who have consumed the powder, according to the Canadian food safety watchdog.
For more news headlines, articles, and equipment reviews, visit our Equipment Zones
More Abbott Laboratories articles:
Abbott Labs Investing $62M in Upgrades at Ohio Plant
You May Also Like